FTSE All-Share
				
					
						5.263,32
					
					PKT
				
				
					
						-2,85
					
					PKT
				
				
					
						-0,05
					
					%
				
			
			
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.11.24 | BP Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 04.11.24 | Unilever Halten | DZ BANK | |
| 04.11.24 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.11.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 01.11.24 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 01.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.11.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 31.10.24 | Glencore Buy | Deutsche Bank AG | |
| 31.10.24 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.24 | GSK Buy | Deutsche Bank AG | |
| 31.10.24 | Glencore Buy | Goldman Sachs Group Inc. | |
| 31.10.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 31.10.24 | GSK Neutral | UBS AG | |
| 31.10.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 31.10.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 30.10.24 | BP Buy | UBS AG | |
| 30.10.24 | GSK Neutral | UBS AG | |
| 30.10.24 | HSBC Buy | Deutsche Bank AG | |
| 30.10.24 | London Stock Exchange (LSE) Hold | Deutsche Bank AG | |
| 30.10.24 | GSK Outperform | Bernstein Research | |
| 30.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.10.24 | Glencore Outperform | RBC Capital Markets | |
| 30.10.24 | HSBC Neutral | UBS AG | |
| 30.10.24 | BP Sector Perform | RBC Capital Markets | |
| 29.10.24 | BP Underweight | JP Morgan Chase & Co. | |
| 29.10.24 | BP Halten | DZ BANK | |
| 29.10.24 | BP Sector Perform | RBC Capital Markets | |
| 29.10.24 | BP Buy | UBS AG | |
| 29.10.24 | HSBC Sector Perform | RBC Capital Markets | |
| 29.10.24 | HSBC Neutral | UBS AG | |
| 29.10.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 28.10.24 | Unilever Overweight | Barclays Capital | |
| 25.10.24 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 25.10.24 | GSK Underweight | JP Morgan Chase & Co. | 
 
                                